Assessing the safety and effectiveness of Atogepant for migraine prevention in Korean adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the safety and effectiveness of Atogepant, an approved medication for migraine prevention, in Korean adults suffering from chronic or episodic migraines. Approximately 3000 participants will be enrolled, all of whom will be prescribed Atogepant by their healthcare providers. Participants will be monitored for up to 12 weeks during routine clinical visits, with no additional burden placed on them. The study aims to gather real-world data on the drug's performance in a clinical setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participants with migraine suitable for the treatment with atogepant according to the latest approved local label.
* Participants prescribed atogepant in accordance with the approved local label.

Exclusion Criteria:

* Participants with any contraindication to atogepant as listed on the latest approved local label.
* Participants currently participating in another clinical research except observational study.

Where it's running

• On Hospital /ID# 285157
  Busan, Busan Gwang Yeogsi, South Korea Recruiting
• Ryu Sang Hyo Neurosurgery Clinic /ID# 284804
  Busan, Busan Gwang Yeogsi, South Korea Recruiting
• Dong-A University Medical Center /ID# 275321
  Busan, Busan Gwang Yeogsi, South Korea Recruiting
• Chungnam National University Hospital /ID# 284724
  Daejeon, Daejeon Gwang Yeogsi, South Korea Recruiting
• Chuncheon Sacred Heart Hospital /ID# 275315
  Gangwon-do, Gang Weondo, South Korea Recruiting
• Chonnam National University Hospital /ID# 275318
  Gwangju, Gwangju Gwang Yeogsi, South Korea Recruiting

Study contacts

• Study coordinator: Celine Im
• Email: celine.im@abbvie.com
• Phone: +82-10-2230-3629

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Real-world use of anti-CGRP medicines for preventing migraine

  This project will follow people with episodic or chronic migraine who start anti-CGRP medicines to see if the treatments reduce migraine frequency and side effects over two years.

  Recruiting at 25 sites Hospital Universitari Vall d'Hebron Research Institute · Miami, Florida and 25 other locations · NCT07159750

• i-NEED: New migraine drugs database

  This project will collect real-life data to see how new migraine treatments—anti‑CGRP antibodies, gepants, ditans, and a sumatriptan‑naproxen combo—work and how well adults with episodic or chronic migraine tolerate them.

  Recruiting at 2 sites IRCCS San Raffaele Roma · Milan, Italy and 1 other locations · NCT07103694

• Analyzing CGRP Levels in Migraine Patients by Age and Sex

  This study looks at the levels of a substance linked to migraines in people with migraines and healthy individuals to see how age and sex might affect treatment responses.

  Recruiting Hospital Universitari Vall d'Hebron Research Institute · Barcelona, Barcelona · NCT06674772

• Evaluating the effectiveness of rimegepant for treating migraines

  This study tests if a new migraine pill called rimegepant can help people with migraines feel better during their attacks and how well they can handle any side effects.

  Recruiting at 2 sites University of Florence · Florence and 1 other locations · NCT05903027

• Comparing telehealth cognitive behavioral therapy for youth with migraines

  This study is testing whether online therapy for kids and teens with migraines works better when combined with medication or on its own.

  Recruiting at 15 sites Children's Hospital Medical Center, Cincinnati · Birmingham, Alabama and 14 other locations · NCT05889624

• Evaluating a lifestyle intervention for chronic migraine management

  This study is testing a new lifestyle program to see if it can help people with chronic migraines feel better compared to a control group.

  Recruiting Mayo Clinic · Phoenix, Arizona · NCT05415020

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.